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Single-port access laparoscopic ovarian transposition 
and cryopreservation of ovarian tissue before chemo- 
radiotherapy in a young woman with rectal cancer
Young Ho Roh, MD, Jiheum Paek, MD, Young Sik Choi, MD, Ji Ann Jung, MD, and Sang Wun Kim, MD
Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea
To introduce the first case of single-port access (SPA) laparoscopic ovarian transposition (LOT) and cryopreservation of 
ovarian tissue before chemo-radiotherapy in a young woman with rectal cancer. We report our experience of SPA-LOT and 
cryopreservation of ovarian tissue with only minimal skin incision. Patient successfully underwent SPA-LOT and cry-
opreservation of ovarian tissue before chemo-radiotherapy in a reasonable time without operative complication in order to 
relocate their ovaries outside the radiation field. A concomitant ovarian wedge resection was performed for ovarian 
cryopreservation. After surgery and chemo-radiotherapy, she continued to have regular menstrual cycles. For a preservation 
of ovarian function, SPA-LOT and cryopreservation of ovarian tissue before chemo-radiotherapy is feasible with only mini-
mal skin incision.
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Introduction
Preservation of ovarian function is an important concern 
in premenopausal cancer patients, especially fertility-desire 
young women, whose treatments include radiation therapy 
to pelvic structures that incorporate the ovaries. Ovarian 
transposition was developed to displace the ovaries from 
their normal anatomic position and away from the direct ra-
diation portal, with the goal of maintaining long-term ovarian 
function. Historically, ovarian transposition was typically 
performed for premenopausal patients undergoing pelvic ir-
radiation for Hodgkin's disease at the time of staging 
laparotomy.1 With the popularization of laparoscopic surgi-
cal techniques, instead of laparotomy, preservation of ovarian 
function by laparoscopic ovarian transposition (LOT) before 
pelvic irradiation has been demonstrated to be a safe and ef-
fective procedure for young patients with malignancies.2-4 
Recently, with improvements in surgical expertise with 
optimal instrumentation, interest in minimally invasive sur-
gery has increased. Single-port access (SPA) laparoscopic 
surgery is one of those innovative techniques. Compared 
with conventional laparoscopy, the SPA surgery offers better 
cosmetic results due to reduced number of inserted trocars. 
Additionally, operative complications related to the trocar 
insertion such as epigastric vessel injury, operative wound 
infection, and hematoma and visceral organ damage may be 
avoided by reducing the number of ancillary ports pene-
trating the abdominal wall. Besides, it has been expected 
that this approach has several advantages, such as faster 
return to normal activity, shorter length of hospital stay, 
lower cost, and reduced pain.5,6 
In this report, the authors introduce the first case of SPA- 
LOT and cryopreservation of ovarian tissue as a means to 
preserve fertility in a 26-year-old woman with rectal cancer 
before concurrent chemotherapy and radiation therapy 




An otherwise healthy 26-year-old female noted watery di-
arrhea, lower abdominal pain, and a 5 kg weight loss for 1 
month. A colonoscopy revealed an encircling ulcerative 
mass in the distal rectum, at approximately 9 cm from the 
anal verge. Multiple biopsies of the mass showed an in-
vasive, moderately differentiated adenocarcinoma. Physical 
examination by a digital rectal exam revealed a 75% circum-
ferential mass with complete fixation. Magnetic resonance 
imaging showed a fungating mass at 9 cm from the anal 
verge with extensive perirectal fat infiltration and direct in-
vasion of posterior circumferential resection margin. In ad-
dition, multiple enlarged lymph nodes were detected in the 
perirectal area, both pelvic side wall, and along the superior 
rectal vessel. On the gynecologic examination, there was no 
abnormal finding. The serum level of carcinoembryonic an-
tigen and CA 19-9 was 0.63 ng/mL and 37.4 U/mL, respectively. 
Other laboratory tests showed no specific abnormality. Her 
height, weight, and body mass index were 164 cm, 48 kg, 
and 17.9 kg/m2, respectively. Based on results of these imag-
ing studies and pathologic reports, the patient was diagnosed 
as locally advanced rectal adenocarcinoma and CCRT was 
planned. Before the onset of radiation therapy, the patient 
was referred for ovarian transposition and cryopreservation. 
The extent of the radiation field was discussed with the gy-
necologic oncologist before the procedure to ensure that the 
transposed ovaries would be outside of the treatment portals. 
SPA system was performed according to a technique pre-
viously described by our group.7,8 Briefly, a Foley catheter 
was placed into the bladder, and a uterine manipulator was 
inserted into the endometrial cavity after general endo-
tracheal anesthesia. After a 1.5 cm vertical intra-umbilical 
skin incision, the Alexis® wound retractor (Applied Medical, 
Rancho Santa Margarita, CA, USA) was inserted into the 
peritoneal cavity through the umbilicus. A 7½ surgical glove 
was fixed to the outer ring of the wound retractor. After 
making a small incision in one of the finger tip portions of 
the glove, two 5 mm trocars and 11 mm trocar were inserted. 
A rigid 30 degree, 5 mm endoscope, conventional laparo-
scopic instruments, and Harmonic Ace (Ethicon Endo-sur-
gery, Cincinnati, OH, USA) were used. Surgical procedure 
of ovarian transposition was performed in the usual fashion. 
The peritoneum of both pelvic sidewalls was incised, and 
the retroperitoneal spaces were developed. The common, 
external, and internal iliac vessels were identified. The ovar-
ian vessels and ureters were traced on both sides (Fig. 1A). 
Under the direct vision of the ureters, the uteroovarian liga-
ment was electrocoagulated and divided with a Harmonic 
Ace. The same procedure was performed on the mesovarium. 
The dissection was continued to an area outside of the true 
pelvis. At this time, the ovarian vessels could be turned lat-
erally with a sufficient angle to maintain appropriate blood 
supply. The tunnel beneath peritoneum was made from the 
end of dissection to the level of the anterior superior iliac 
spine (Fig. 1B). The mobilized ovaries and tubes were 
passed through this tunnel and anchored to the peritoneum 
out of the tunnel, with Vicryl 2-0 continuous suture. The up-
per and lower poles of the ovaries were marked with hemo-
clips (Fig. 1C). A concomitant ovarian wedge resection was 
performed for ovarian cryopreservation. Approximately one 
third to half of the left ovary was excised using laparoscopic 
scissors (Fig. 1D). 
Before dissecting the ovarian cortical tissue for cry-
opreservation, all visible follicles were aspirated with an 18 
gauge syringe needle that was attached to a 10 mL syringe. 
The aspirates were flushed in oocyte washing medium 
(CooperSurgical/Sage, Trumbull, CT, USA) and searched 
for cumulus–oocyte complexes under the dissecting 
microscope. Following follicle aspiration, the ovarian cort-
ical tissues were isolated in the oocyte washing medium, cut 
into 4 mm3 (2×2×1) pieces, and searched for the presence of 
additional oocytes. Immature oocytes were matured in an 
organ tissue culture dish (60×15 mm2; Falcon, Franklin 
Lakes, NJ, USA) containing 1.0 mL of In vitro maturation 
medium (Coopersurgical/Sage) supplemented with a final 
concentration of 75 mIU/mL of follicle-stimulating hor-
mone (FSH) and luteinizing hormone (LH) at 37°C in an at-
mosphere of 5% CO2 in air with high humidity. Ovarian tis-
sue cryopreservation was performed as previously described.
SPA-LOT and cryopreservation of ovarian tissue was per-
formed without a conversion to conventional laparoscopy or 
laparotomy. The operative time was 100 minutes and esti-
mated blood loss was 10 mL. There was no perioperative 
complication. The patient was discharged on postoperative 
day 2 without complication. After the surgery, patient was 
evaluated and consulted by a reproductive endocrinology 
and infertility specialist. She was scheduled to undergo pel-
vic irradiation and combination of 5-fluorouracil and 
leucovorin. On postoperative day 10, she underwent the first 
dose of CCRT. She completed whole process of scheduled 
CCRT for 5 weeks without any complication. The patient re-
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Fig. 1. Intraoperative view of single-port access laparoscopic ovarian transposition and cryopreservation; (A) the ovarian vessels 
and ureter were traced, (B) tunneling of peritoneum, (C) attachment of relocated ovary with intracorporeal suturing and clipping, 
(D) ovarian wedge resection for cryopreservation.
ceived a total dose of 4500 cGy to the pelvis, complemented 
by a 450 cGy boost to the mesorectum, in 25 daily fractions 
of 180 cGy each over 5 weeks. Treatment was delivered us-
ing 10 MV photons, 5 days a week. The ovaries were de-
termined to be outside of the radiation fields, as visualized 
by the radiographic clips placed at the time of laparoscopy 
(Fig. 2A, 2B). The fields for external radiation were lo-
calized with a radiotherapy simulator (Fig. 2C, 2D). We 
used 2 times of GnRH analogue for CCRT. She was planned 
to undergo surgery 6 weeks after completion of CCRT. 
Ovarian function was assessed by measurement of serum 
FSH and LH levels at immediately after surgery and CCRT.9 
The values were 6.6 mIU/mL and 124 pg/mL, respectively. 
It was considered normal when the FSH and LH level was 
between 1.5-33.4 mIU/mL and 30-330 pg/mL. Her menstru-
al cycle was resumed at 5 months after CCRT with normal 
flow and without dysmenorrhea. 
Discussion
Only a few short series of LOT have been reported1-4,10 
and, recently, Pahisa et al.11 demonstrated that LOT was a 
safe and effective procedure for the preservation of ovarian 
function in young patients with early cervical cancer under-
going adjuvant radiotherapy after surgery by a prospective 
study with long term follow-up. The laparoscopic approach 
enables the patient to return to normal activity and to start 
radiation within days of the procedure. In addition, young 
women who preserve her fertility require minimally in-
vasive surgery which has minimum operation scar and re-
duced postoperative pain. For this reason, SPA-LOT is ex-
pected as a surgical option for these demands with minimum 
invasion. 
In this report, we could perform SPA-LOT and ovarian 
cryopreservation in a reasonable time without operative 
A                                                        B
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Fig. 2. (A, B) The ovaries were determined to be outside of the radiation fields, as visualized by the radiographic clips placed at the 
time of laparoscopy. (C, D) The fields for external radiation.
complication. To successfully perform LOT, suturing for the 
detachment of ovary and sufficient dissection of ureter are 
essential. However, the SPA surgery has systemic limi-
tations, including a crush between instruments or between 
instruments and endoscope, a limited amount of instru-
ments, and limited mobility of straight laparoscopic instru-
ments because surgical instruments work through only one 
port. These technical problems cause lower accuracy of the 
operation compared to conventional laparoscopy. The authors 
have solved the technical problems in the SPA surgery using 
conventional laparoscopic instruments. A 40 cm length, 5 
mm diameter, and 30 degree angled endoscope and a 90 degree 
light cable adaptor were used to avoid collision between en-
doscope and surgical instruments. Additionally, the authors 
made a middle portion of a toothed biopsy forcep slightly 
curved thereby avoiding the collision of surgical instruments. 
A                                                    B
C                                                           D
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For traction of tissue, the 2-mm grasper was added and this 
instrument was flexible so that adding it did not cause a 
crash between other surgical instruments. For performing dou-
ble tying, an articulated instrument such as the RoticulatorTM 
(Covidien, Mansfield, MA, USA) was used. Its handle was 
not too big so the operator could avoid the collision between 
instruments. Additionally, 3 cm length tunnel was made at 
the peritoneum for a detachment of the ovary. The mobilized 
ovaries and tubes were passed through this tunnel and anch-
ored to the peritoneum out of the tunnel with suturing and 
surgical clips. In this report, the authors focused on the in-
troduction of minimally invasive surgery for LOT. Therefore, 
after surgery, quantitative analysis of ovary-stimulating or 
ovary-producing hormones as well as assessment of sub-
sequent pregnancy outcome is additionally needed. 
In conclusion, SPA-LOT and ovarian cryopreservation 
using single multi-channel port could be feasible procedure 
in young cancer patient who desire preserving of ovarian 
function with only minimal skin incision. Prospective 
randomized trials will permit the evaluation of potential ben-
efits of this minimally invasive surgical technique.
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